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The dose-response curves of epinephrine given either IV or endotracheally (ET) were compared 
during resuscitation from electromechanical dissociation (EMD). Ten anesthetized dogs were 
subjected to a two-minute period of electrically induced ventricular fibrillation (VF) followed by 
defibrillation without CPR to produce EMD. Mechanical CPR was followed by injection of 
either ET or IV epinephrine. Successful response was defined as a return of pulsatile blood 
pressure within two minutes of drug administration. Using log-dose increments of epinephrine, 
experimental trials were repeated in each animal. The IV and ET median effective doses were 14 
and 130 g/kg, respectively. When the trials were successful, the time between drug 
administration and either arterial blood pressure increases or return of spontaneous circulation 
did not differ significantly for the ET and IV groups. These results show that the dosage for 
epinephrine delivered ET must be higher than the IV dosage to achieve the same response during 
CPR.  
 
[Ann Emerg Med November 1985;14(11):1044-1048.] 
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Epinephrine has been the most thoroughly evaluated drug used in advanced cardiac life support. 
A succession of studies, beginning with Crile in 1906,
1
 have shown repeatedly that when 
epinephrine is added to resuscitation procedures following cardiac arrest, the victim's chances of 
survival are improved significantly. Redding's work in the 1960s established that the value of 
epinephrine lies principally in its alpha agonist activity, which produces peripheral 
vasoconstriction, increased blood pressure, and improved myocardial perfusion.
2-5
 The 




Because the IV route of drug delivery may be difficult and time consuming during periods of 
circulatory arrest, the American Heart Association (AHA) currently recommends that 
epinephrine also be given through the endotracheal tube.
9
 Established protocol requires that 
epinephrine be given in 0.5-mg to 1-mg doses IV and repeated at five-minute intervals until the 
circulation is restored. Based on Greenberg's studies in animals with normally beating hearts,
10,11
 
the AHA recommends that 1 mg epinephrine diluted in a 10-mL solution be given through the 
endotracheal tube as an alternative to the IV route. Pilot studies in our laboratory revealed 
difficulties in eliciting blood pressure responses using the recommended protocol for 
tracheobronchial epinephrine administration.
8
  In these pilot studies, three anesthetized dogs 
were subjected to electrically induced ventricular fibrillation (VF), and CPR was started 
immediately. We observed no change in blood pressure following injection of endotracheal 
epinephrine (0.1 mg/kg); however, deep intrapulmonary epinephrine* (0.1 mg/kg) increased the 
blood pressure within a few seconds. In addition the blood pressure did not increase following 
either tracheal or deep bronchial injection of epinephrine in the currently recommended doses. 
These observations led us to speculate that during the low-blood-flow state that exists during 
CPR, epinephrine is not absorbed readily through the conducting airways, and that the currently 
recommended dosage may be too low to be effective. We therefore undertook a study to compare 






Ten mongrel dogs of either sex weighing 13 kg to 29 kg (mean, 22.6 kg) were anesthetized with 
IV pentobarbital sodium (30 mg/kg) and intubated with a cuffed endotracheal tube. Intravascular 
catheters were placed to monitor pressures in the right atrium, aortic arch, and left ventricle. The 
animals were heparinized (1 mg/kg) to retard intravascular coagulation at the catheter tips. 
Physiologic monitoring was done on a Physiograph recorder (Narco Bio-systems, Houston, 
Texas). Four channels of data were recorded -- ECG lead II, aortic arch pressure, central venous 











The animal model used in our study was developed previously by Thijs and associates
12
 and 
reproduced in studies by other investigators.
13,14
 The model was designed to simulate clinical 
situations in which defibrillation occurs without adequate coronary perfusion, producing EMD. 
VF was induced electrically using five- to ten-volt, 60-Hz electric pulses applied to the left 
ventricular catheter, which contained a 0.1-mm stainless steel wire within the lumen to carry 
current to the heart. After two minutes of VF, a defibrillation countershock was applied and 
repeated if necessary until cardiac electrical activity resumed. During the next 30 seconds, EMD 
was confirmed by observing the ECG and pressure channels to be certain that electrical activity 
remained without evidence of any blood pressure pulses.  
 
At this point, standard CPR was initiated using a mechanical Thumper
®
 (Michigan Instruments, 
Grand Rapids, Michigan) to provide chest compressions and ventilation. After pressures were 
stabilized the test drug was administered and CPR was continued. CPR was discontinued as soon 
as the graphic record showed evidence of returning pulsatile blood pressure or a maximum of 
two minutes after drug administration. Animals that were able to maintain their own circulation 
at this time were termed successes, and those that required further help were termed failures. 
Additional measures were used to resuscitate the latter group so that further experimental trials 
could be performed. These measures included increasing the chest compression force to improve 
CPR and/or giving intracardiac epinephrine. This experimental procedure (Figure 1) was 
repeated using logarithmically incremental epinephrine doses until the animal no longer could 
maintain a diastolic arterial pressure of 100 mm Hg.  
 
Time intervals were interspersed between trials to allow for drug metabolism and animal 
recovery. Following IV dosing the recovery period was 30 minutes, or more than five half-lives 
of epinephrine. In the absence of pharmacokinetic studies for this endotracheal model, the 
recovery period was one hour, or approximately three times longer than the time required for 







Fig. 1. Diagrammatic representation of protocol for each experimental trial. 
 
 
In order to evaluate the effectiveness of epinephrine, it is important to select an animal model in 
which CPR alone is unable to restore the circulation successfully. Therefore, in the first 
experimental trial each animal received saline as the test drug, and the chest compression force 
was adjusted to produce a diastolic pressure of approximately 20 mm Hg. The experiment 
continued only after failure to resuscitate within two minutes was confirmed using CPR and 
saline. The arterial blood pressures achieved during this trial were maintained throughout 
subsequent trials. 
 
Drug Administration Techniques  
 
Following an experimental trial using saline as the test drug, epinephrine was given as a bolus 
either IV or ET, and the route was alternated in subsequent experimental trials. In half the dogs 
the IV route was used first, and in the other half the ET route was used first. The initial drug 
dosage for each route (10 g/kg IV or 100 g/kg diluted in 10 mL saline ET) was selected to 
have a reasonable chance of success based on prior observations in other animals. Subsequent 
drug dosage was based on the outcome from the first experimental trial. When the initial dose 
was effective in restoring the circulation, a lower dose was then given; if ineffective, a higher 
dose was used. 
 
ET drug delivery was accomplished using a 13-F, 50-cm-long catheter equipped with a spray 
nozzle on the distal tip (experimental model, Cook Inc, Bloomington, Indiana). The catheter, 
which produced a fine mist spray, was advanced to a position within the trachea approximately 
three inches distal to the end of the ET tube. The drug was sprayed quickly into the trachea, 
followed by air injection to clear the catheter. Then two to three full, maximal ventilations were 








A cumulative frequency distribution was constructed using successful resuscitations within two 
minutes as the end response for each drug dose administered. In constructing these curves it was 
assumed that if success had been achieved with dose, X, in a given animal, then success also 
would have been achieved with doses larger than X in that animal, even though all larger doses 
may not have been tested in that animal. This analytical approach is similar to that described by 
Goldstein and associates for constructing dose-response curves from the distribution of drug 
sensitivities.
15
 The median effective dose (ED50) was derived following Probit transformation of 




To determine further the effects of epinephrine dosage, additional variables were assessed when 
the resuscitation trials were successful. These variables included the time from drug delivery to 
evidence of initial blood pressure response, the time from drug delivery to return of spontaneous 
circulation, the post-resuscitation peak arterial systolic and peak diastolic pressures, and the 






Fig. 2. Physiologic tracing from a dog following epinephrine injection during CPR. 
Illustrations include onset of arterial blood pressure response, onset of returning 





The initial blood pressure response following drug administration was defined by the intersection 
of two lines drawn at the base of the control CPR pressures and at the base of the rising pressure 
slope (Figure 2). The return of spontaneous circulation was coincident with blood pressure pulses 
superimposed on the Thumper
®
-generated pulses. The duration of hypertension included the time 
period when the blood pressure exceeded 140/80 mm Hg. An ANOVA was performed on these 
data to test the null hypothesis that population means were equal within the groups using the  




In the ten animals epinephrine was given in 21 IV doses and 19 ET doses. Ten IV and nine ET 
epinephrine doses were successful in promoting a return of spontaneous circulation. The 
relationships between epinephrine concentration and the cumulative percentage of successful 
resuscitations are shown (Figure 3). Epinephrine given by the ET route required doses that were 
approximately ten times higher than the epinephrine doses required for the IV route. The IV and 





Fig. 3. Cumulative dose-response relationships for recovery of animals following 





Blood pressures were assessed during the short period of CPR just prior to the administration of 
epinephrine. Aortic diastolic pressures for the IV and ET groups were 19.9  1.02 mm Hg and 
18.53  0.65 into Hg (mean  SE), respectively. The pre-drug coronary perfusion pressures 
(aortic pressure minus right atrial pressure) were 7.62  0.6 mm Hg for the IV trials and 7.78  
0.65 mm Hg for the ET trials. These baseline pressures did not vary significantly between IV and 
ET groups. 
 
Evidence for early epinephrine effect was assessed by measuring the onset of blood pressure rise 
and the initial evidence of spontaneous pulsatile blood pressure. There were no significant 
differences between the IV and ET groups (Table) in either of these parameters. To determine 
the action of epinephrine in the immediate post-recovery period, the peak arterial pressures and 
the duration of the hypertensive episode were measured. Both systolic and diastolic arterial blood 
pressures achieved were significantly higher following the higher-dose ET epinephrine 
injections, compared with the lower doses given IV (Table). In addition the hypertensive event 








The results of our study indicate that epinephrine must be given in a much higher dosage by the 
ET route compared with the central venous route in order to restore circulation following cardiac 
arrest associated with EMD. These results are consistent with studies by Roberts and 
coworkers,
10
 who demonstrated blood levels of epinephrine to be ten times lower with ET 
epinephrine compared with IV epinephrine. These findings suggest that the higher dose 
requirement for the ET drug during CPR reflects the amount of drug actually absorbed into the 
circulation by the pulmonary capillary bed. The ET-injected drug presumably remains partially 
in the conducting airways, where it is poorly absorbed, particularly during the low-blood-flow 
state associated with CPR. The result is an inadequate delivery of drug to the deep absorbent 
surfaces of the alveolar membranes.  
 





 Elam and coworkers described a prolonged drug effect following ET administration 
that they attributed to a "depot" of drug that produced an IV drip effect delivering small 
8 
 
increments of drug over a fairly long period. Roberts and colleagues also found that ET 
epinephrine significantly prolonged both the pharmacological effects and the epinephrine blood 
levels compared with IV administration. 
 
Techniques aimed at dispersing the drug more quickly into the lower airways have been 
developed in the laboratory. Elam raised the animal's head 30 degrees and used a long catheter 





undiluted epinephrine (1 mg in 1 mL solution) given ET to be unsuccessful during resuscitation. 
By diluting epinephrine in 10 mL saline or water, however, greater absorption occurred, resulting 
in resuscitation successes equal to those of IV or intracardiac delivery. Greenberg and Spivey
19
 
demonstrated the importance of forceful ventilations to maximize the distribution of drug into 
the deeper lung surfaces. With the exception of raising the animals head, we used all these 
techniques to maximize drug dispersion. In addition the catheter chosen for these experiments 
was one capable of producing a finer spray than other currently available products. By 
optimizing ET delivery we hoped to produce the optimal dose-response to epinephrine. The ET 
route, however, still required epinephrine doses ten times higher than the IV route to effect 
successful resuscitation. 
 
The effectiveness of epinephrine also has been related to the timing of its delivery during the 
resuscitation procedure. Redding noted that epinephrine responsiveness decreased when drug 
delivery was delayed following cardiac arrest, resulting in fewer successful resuscitations.
5
 The 
site for drug injection during CPR may play a crucial role in aiding early delivery. Previous 
studies reported a more rapid onset of epinephrine effects following ET injection compared with 
femoral IV injection.
17
 By bypassing a sluggish circulation, the ET route provided a shorter 
pathway to the peripheral vasculature. In our study the onset of drug effects following ET 
delivery compared favorably with the central IV route. These findings indicate that a portion of 
the large ET bolus is absorbed immediately into the circulatory system. 
 
Establishing an effective epinephrine dosage during CPR is a worthwhile yet difficult problem. 
Currently the AHA recommends giving 0.5 to 1 mg (equivalent to 7.5 g/kg to 15 g/kg in a 70-
kg man) epinephrine IV or 1 mg ET.
9
 In our study, epinephrine dosages required to bring about 
successful recovery of the circulation greatly exceeded the current recommendations. Four of the 
successful IV doses were double the recommended human value; the nine successful ET doses 
exceeded the AHA standards by factors ranging from seven to 40. Recently Kosnik and 
coworkers found that centrally administered IV doses of epinephrine ranging up to ten times the 
recommended dosage did not increase coronary perfusion pressures significantly in dogs during 
VF and CPR.
20
 These findings suggest that the effective epinephrine dosage during CPR may be 
higher than the current recommendations. 
 
Additional factors influence the amount of epinephrine required to raise the arterial blood 
pressure and restore the circulation. For example, the amount of blood flow generated by CPR 
and the individual's responsiveness to epinephrine are two such factors. To minimize the effects 
of these factors, our study compared dose-responses to ET and IV epinephrine in the same 
animal using CPR that was standardized to produce comparable blood pressures during each 
trial. The effectiveness of the doses reported in the study likely depends on the blood flow that 
9 
 
was achieved. If the blood flow differs, the effective dose may differ. We attempted to illustrate 
the differences in dose requirements for the two routes by comparing epinephrine dose-responses 
in the same animal under similar conditions. Increasing the dosage of this powerful 
vasoconstrictor drug may be a requirement for resuscitation success. 
 
After the circulation is restored, however, high levels of epinephrine may produce dangerous 
side effects. A period of severe hypertension that was related to the amount of the drug delivered 
occurred during the recovery period. The duration of the hypertensive episode was greater when 
epinephrine was given by the ET route and also was dose related. During this hypertensive 
episode the already compromised heart must work against an increased afterload, causing further 




Our study has shown that ET epinephrine dosage must be much higher than the IV dosage to 
achieve the same results during resuscitation from electromechanical dissociation. When an 
effective dosage is given, no difference exists between these routes in the time required to elicit a 
blood pressure response or in the time to establish circulatory recovery. The hypertension 
following recovery, however, is both more severe and longer lasting when these higher ET doses 
are used. 
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